These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16597680)

  • 41. Renal vasodilatory response to intravenous glycine in the aging rat kidney.
    Baylis C; Fredericks M; Wilson C; Munger K; Collins R
    Am J Kidney Dis; 1990 Mar; 15(3):244-51. PubMed ID: 2305764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of recombinant human relaxin upon proliferation of cardiac fibroblast and synthesis of collagen under high glucose condition.
    Wang P; Li HW; Wang YP; Chen H; Zhang P
    J Endocrinol Invest; 2009 Mar; 32(3):242-7. PubMed ID: 19542742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renin-angiotensin system inhibition reduces glycine-induced glomerular hyperfiltration in conscious rats.
    Wang YX; Brooks DP
    J Pharmacol Exp Ther; 1992 Apr; 261(1):96-100. PubMed ID: 1560388
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relaxin is essential for renal vasodilation during pregnancy in conscious rats.
    Novak J; Danielson LA; Kerchner LJ; Sherwood OD; Ramirez RJ; Moalli PA; Conrad KP
    J Clin Invest; 2001 Jun; 107(11):1469-75. PubMed ID: 11390429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The local administration of relaxin induces changes in the microcirculation of the rat mesocaecum.
    Bigazzi M; Del Mese A; Petrucci F; Casali R; Novelli GP
    Acta Endocrinol (Copenh); 1986 Jun; 112(2):296-9. PubMed ID: 3739555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pharmacokinetics of recombinant human relaxin in nonpregnant women after intravenous, intravaginal, and intracervical administration.
    Chen SA; Perlman AJ; Spanski N; Peterson CM; Sanders SW; Jaffe R; Martin M; Yalcinkaya T; Cefalo RC; Chescheir NC
    Pharm Res; 1993 Jun; 10(6):834-8. PubMed ID: 8257492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The pharmacokinetics and absorption of recombinant human relaxin in nonpregnant rabbits and rhesus monkeys after intravenous and intravaginal administration.
    Chen SA; Reed B; Nguyen T; Gaylord N; Fuller GB; Mordenti J
    Pharm Res; 1993 Feb; 10(2):223-7. PubMed ID: 8456068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Grape Powder Improves Age-Related Decline in Mitochondrial and Kidney Functions in Fischer 344 Rats.
    Pokkunuri I; Ali Q; Asghar M
    Oxid Med Cell Longev; 2016; 2016():6135319. PubMed ID: 27528887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emerging role of relaxin in renal and cardiovascular function.
    Conrad KP; Novak J
    Am J Physiol Regul Integr Comp Physiol; 2004 Aug; 287(2):R250-61. PubMed ID: 15271674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The aging kidney: insights from experimental studies.
    Baylis C; Corman B
    J Am Soc Nephrol; 1998 Apr; 9(4):699-709. PubMed ID: 9555673
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic administration of recombinant human relaxin (RHRLX) ameliorates the acute cyclosporine nephrotoxicity in rats.
    Huang X; Cheng Z; Sunga J; Unemori E; Zsebo K
    J Heart Lung Transplant; 2001 Feb; 20(2):253. PubMed ID: 11250506
    [No Abstract]   [Full Text] [Related]  

  • 52. [Organ alterations due to aging].
    Wieczorowska-Tobis K
    Pol Arch Med Wewn; 2008; 118 Suppl():63-9. PubMed ID: 19562974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Kidney in Aging: Physiological Changes and Pathological Implications.
    Sobamowo H; Prabhakar SS
    Prog Mol Biol Transl Sci; 2017; 146():303-340. PubMed ID: 28253989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The occurrence of renal changes, resembling nephrosis, in rats poisoned with fluorocitrate.
    CATER DB; PETERS RA
    Br J Exp Pathol; 1961 Jun; 42(3):278-89. PubMed ID: 13691556
    [No Abstract]   [Full Text] [Related]  

  • 55. Age changes in the renal basement membrane in rats.
    ASHWORTH CT; RDMANN RR; ARNOLD NJ
    Am J Pathol; 1960 Feb; 36(2):165-79. PubMed ID: 13794780
    [No Abstract]   [Full Text] [Related]  

  • 56. Renal pathology and aging.
    Wagner BM
    Hum Pathol; 1987 Jul; 18(7):659-60. PubMed ID: 3596586
    [No Abstract]   [Full Text] [Related]  

  • 57. Enhancing the Therapeutic Potential of Mesenchymal Stromal Cell-Based Therapies with an Anti-Fibrotic Agent for the Treatment of Chronic Kidney Disease.
    Li Y; Ricardo SD; Samuel CS
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-apoptotic and Matrix Remodeling Actions of a Small Molecule Agonist of the Human Relaxin Receptor, ML290 in Mice With Unilateral Ureteral Obstruction.
    Ng HH; Soula M; Rivas B; Wilson KJ; Marugan JJ; Agoulnik AI
    Front Physiol; 2021; 12():650769. PubMed ID: 34305630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. H3 relaxin protects against calcium oxalate crystal-induced renal inflammatory pyroptosis.
    Liu J; Yang K; Jin Y; Liu Y; Chen Y; Zhang X; Yu S; Song E; Chen S; Zhang J; Jing G; An R
    Cell Prolif; 2020 Oct; 53(10):e12902. PubMed ID: 32945585
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis.
    Chow BSM; Kocan M; Shen M; Wang Y; Han L; Chew JY; Wang C; Bosnyak S; Mirabito-Colafella KM; Barsha G; Wigg B; Johnstone EKM; Hossain MA; Pfleger KDG; Denton KM; Widdop RE; Summers RJ; Bathgate RAD; Hewitson TD; Samuel CS
    J Am Soc Nephrol; 2019 Nov; 30(11):2191-2207. PubMed ID: 31511361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.